ETHYOL

Marca svizra · 371850 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
371850
Numer da la dumonda
02715/1989
Status
En vigur
Tip
Marca da pled
Deponida
07-04-1989
Registrada
21-08-1989
Publitgada
22-09-1989
Protegida fin ils
07-04-2029
Lingua da la procedura
franzos
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Medizinische und pharmazeutische Präparate.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 03-10-2023

    Represchentant stritgà

    Representative
    SEDIN SA, 24, rue Merle d'Aubigné, 1207 Genève (allontanà)

    Published in Swissreg on 03.10.2023

  2. 03-10-2023

    Transferì

    Owner
    Clinigen Limited, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom → CNX THERAPEUTICS LIMITED, 3 Bunhill Row, London, EC1Y 8YZ, United Kingdom
    Representative
    SEDIN SA, 24, Rue Merle d'Aubigné, 1207 Genève

    Published in Swissreg on 03.10.2023

  3. 29-09-2022

    Curregì

    Owner
    Clinigen Group LLC, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom → Clinigen Limited, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom

    Published in Swissreg on 29.09.2022

  4. 27-09-2022

    Adressa dal possessur midada

    Owner
    Clinigen Group Plc, Pitcairn House, Crown Square, Centrum 100, Burton on Trent, Staffordshire DE14 2WW, United Kingdom → Clinigen Group LLC, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom

    Published in Swissreg on 27.09.2022

  5. 08-03-2019

    Prolungà

    Published in Swissreg on 08.03.2019

  6. 05-03-2019

    Represchentant stritgà

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (allontanà)

    Published in Swissreg on 05.03.2019

  7. 05-03-2019

    Transferì

    Owner
    MedImmune, LLC, One MedImmune Way, Gaithersburg MD 20878, USA → Clinigen Group Plc, Pitcairn House, Crown Square, Centrum 100, Burton on Trent, Staffordshire DE14 2WW, United Kingdom
    Representative
    SEDIN SA, 24, rue Merle d'Aubigné, 1207 Genève

    Published in Swissreg on 05.03.2019

  8. 21-01-2009

    Prolungà

    Published in Swissreg on 21.01.2009

4 endataziuns pli veglias
  1. 16-01-2009

    Transferì

    Owner
    MedImmune Oncology, Inc., One Tower Bridge,, 100 Front Street, Suite 400, West Conshohocken, USA → MedImmune, LLC, One MedImmune Way, Gaithersburg MD 20878, USA
    Representative
    Kirker & Cie, Conseils en Marques SA, 14, rue du Mont-Blanc, 1201 Genève → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 16.01.2009

  2. 22-11-2000

    Adressa dal possessur midada

    Owner
    U.S. Bioscience, Inc., One Tower Bridge, 100 Front Street, West Conshohocken (PA), USA → MedImmune Oncology, Inc., One Tower Bridge,, 100 Front Street, Suite 400, West Conshohocken, USA

    Published in the SOGC no. 228 of 22.11.2000

  3. 22-11-1994

    Transferì

    Owner
    Sterling Drug Inc., 90 Park Avenue, New York (NY), USA → U.S. Bioscience, Inc., One Tower Bridge, 100 Front Street, West Conshohocken (PA), USA

    Published in the SOGC no. 227 of 22.11.1994

  4. 22-09-1989

    Registrà

    Published in the SOGC no. 185 of 22.09.1989

Partidas

Possessura

CNX THERAPEUTICS LIMITED

3 Bunhill Row, London, EC1Y 8YZ, GB

Represententa

Sedin SA

SEDIN SA

24, Rue Merle d'Aubigné, 1207 Genève

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.